Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy

A new study in The Lancet, Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial, explores why postoperative chemoradiotherapy does not provide a survival benefit over chemotherapy  Researchers explain preoperative treatment strategies may provide more benefit to patients who have resectable gastric cancer.